Difference between revisions of "Team:Aix-Marseille/HP/Gold Integrated"

Line 1: Line 1:
 
{{Aix-Marseille|title=Integrated Human Practices|toc=__TOC__}}
 
{{Aix-Marseille|title=Integrated Human Practices|toc=__TOC__}}
  
 +
[[File:Tree.png|500px|right|thumb|Human Practices Development]]
  
Each project or product is defined by its use and by its regulations. This is why since the beginning of our project, we have wanted to integrate the opinion of those who shall use it, farmers, and those who will authorize it, lawyers.  
+
We have thought about the Human Practices since the very beginning of [[Team:Aix-Marseille/Project|'''KILL XYL''']]. We had drawn the limits of it and found out which actors were going to be involved in deciding our scientific approach. This way our project could be as adapted as possible to the factual needs of society.
  
To integrate the farmer’s opinion, we contacted them and did a [[Team:Aix-Marseille/HP/Surveys|surveys]], first via the web, and then in person, during [[Team:Aix-Marseille/Engagement#Salon_des_Agricultures_de_Provence|events around agriculture]]. This approach helped us to figure out their needs and their thoughts, about Xylella fastidiosa and the communication around it.
+
Then, the more our [[Team:Aix-Marseille/Project|project]] advanced and defined itself, the more we worked on the practical side of Human Practices.  
  
...
+
First and foremost [[Team:Aix-Marseille/Safety|safety]]  is crucial in a lab. To work in synthetic biology, we ask our self about the consequences of our manipulation and the safety level of each part and organisms that we used. We also always make sure to work with the best condition and we didn't experiment with P2 level organisms. We also wanted to make sure that our product, especially our phage-like particle as it is a GMO, is environmentally friendly and doesn't pollute the soil or harm plant. To do so, we did [[Team:Aix-Marseille/M13_test|test]] our phages in various conditions.
  
We got advice from different experts : [[Team:Aix-Marseille/HP/Interviews#Mireille_ANSALDI|Mireille Ansaldi]], the research director of the phage cycle and bacteria metabolism in LCB CNRS ; [[Team:Aix-Marseille/HP/Interviews#Marie-Agn.C3.A8s_JACQUES|Marie-Agnès Jacques]], INRA’s researcher specialised in Xylella fastidiosa, and [[Team:Aix-Marseille/HP/Interviews#Jacques_VAN_HELDEN|Jacques Van Helden]], professor in Aix-Marseille Université in bioinformatics, genome analysis, and more specifically analyses of regulatory sequences.
+
To integrate the farmer’s opinion, we contacted them and did [[Team:Aix-Marseille/HP/Surveys|surveys]], first via the web and then in person, during  [[Team:Aix-Marseille/Engagement#Salon_des_Agricultures_de_Provence|events around agriculture]]. This approach helped us to figure out their needs and their thoughts, about [[Team:Aix-Marseille/Xylella_fastidiosa|''Xylella fastidiosa'']] and the communication around it.
  
These three experts helped us a great deal. [[Team:Aix-Marseille/HP/Interviews#Mireille_ANSALDI|Ms. Ansaldi]] first guided us toward the phage M13 because we wanted to use a bacteriophage to get rid of Xyllela fastidiosa. In the end, we didn’t, but we did use phages as a specific capsule.
+
We got [[Team:Aix-Marseille/HP/Interviews|advices]] from different experts [[Team:Aix-Marseille/HP/Interviews#Mireille_ANSALDI|Mireille Ansaldi]], the research director of the phage cycle and bacteria metabolism in LCB CNRS; [[Team:Aix-Marseille/HP/Interviews#Marie-Agn.C3.A8s_JACQUES|Marie-Agnès Jacques]], INRA’s researcher specialised in [[Team:Aix-Marseille/Xylella_fastidiosa|''X. fastidiosa'']], and [[Team:Aix-Marseille/HP/Interviews#Jacques_VAN_HELDEN|Jacques Van Helden]], professor in Aix-Marseille University in bioinformatics, genome analysis, and more specifically analyses of regulatory sequences.
  
Then, when we began dry lab work, [[Team:Aix-Marseille/HP/Interviews#Jacques_VAN_HELDEN|M. Van Helden]] help us with our human practices questioning about specificity and controllability of our project. He also helped us for the dry lab.
+
Finally, in order to get advice on the relevance of our project we contacted Ms Jacques, a [[Team:Aix-Marseille/Xylella_fastidiosa|''X. fastidiosa'']] specialist from the Institut National de la Recherche Agronomique(INRA). She beware us that we would be defined by the legislation as a GMO product. We then began a complete study of [[Team:Aix-Marseille/Legislation|french’s and European's law]], thanks to a collaboration with the [https://2017.igem.org/Team:Evry_Paris-Saclay|Evry Paris-Saclay] team to see if we will be able to sell our product in France and in Europe.
  
 
+
To sum up, our project grew entwined with the human practices.
Finally, in order to get advice on the relevance of our project, we contacted [[Team:Aix-Marseille/HP/Interviews#Marie-Agn.C3.A8s_JACQUES|Ms. Jacques]], a ''Xyllela fastidiosa'' specialist from the INRA (Institut National de la Recherche Agronomique). She beware us that we would be defined by the legislation as a GMO product. We then began a complete study of [[Team:Aix-Marseille/Legislation|french’s and European's law]] to see if we will be able to sell our product in France and in Europe.
+
  
 
<div class="row-icons white-icons">
 
<div class="row-icons white-icons">
* [[File:T--Aix-Marseille--spirit.png|link=Team:Aix-Marseille/Team_Spirit]]<span class="legend">Team Spirit</span>
 
 
* [[File:T--Aix-Marseille--survey.png|link=Team:Aix-Marseille/HP/Surveys]]<span class="legend">Survey</span>
 
* [[File:T--Aix-Marseille--survey.png|link=Team:Aix-Marseille/HP/Surveys]]<span class="legend">Survey</span>
 
* [[File:T--Aix-Marseille--interview.png|link=Team:Aix-Marseille/HP/Interviews|Interview]]<span class="legend">Interviews</span>
 
* [[File:T--Aix-Marseille--interview.png|link=Team:Aix-Marseille/HP/Interviews|Interview]]<span class="legend">Interviews</span>
 
* [[File:T--Aix-Marseille--legislation.png|link=Team:Aix-Marseille/Legislation|Legislation]]<span class="legend">Legislation</span>
 
* [[File:T--Aix-Marseille--legislation.png|link=Team:Aix-Marseille/Legislation|Legislation]]<span class="legend">Legislation</span>
* [[File:T--Aix-Marseille--icon-silver.png|link=Team:Aix-Marseille/HP/Silver]]<span class="legend">Silver medal</span>
 
 
* [[File:T--Aix-Marseille--Public.png|link=Team:Aix-Marseille/Engagement]]<span class="legend">Public Engagement</span>
 
* [[File:T--Aix-Marseille--Public.png|link=Team:Aix-Marseille/Engagement]]<span class="legend">Public Engagement</span>
 
</div>
 
</div>
 
 
<h1>Gold Medal and Integrated Human Practices</h1>
 
 
<p>This page will contain information for your Gold medal Human Practices work, which you can also use to nominate your team for the Best Integrated Human Practices page. To make things easier, we have combined the Gold medal page with the Best Integrated Human Practices page since we expect the work to overlap considerably. </p>
 
<p>iGEM teams are unique and leading the field because they "go beyond the lab" to imagine their projects in a social/environmental context, to better understand issues that might influence the design and use of their technologies.</p>
 
<p>Teams work with students and advisors from the humanities and social sciences to explore topics concerning ethical, legal, social, economic, safety or security issues related to their work. Consideration of these Human Practices is crucial for building safe and sustainable projects that serve the public interest. </p>
 
<p>For more information, please see the <a href="https://2017.igem.org/Competition/Human_Practices">Human Practices page</a>.</p>
 
</div>
 
<div class="clear"></div>
 
 
 
<div class="column half_size">
 
<h3>Gold Medal Criterion #1</h3>
 
<p>Expand on your silver medal activity by demonstrating how you have integrated the investigated issues into the design and/or execution of your project.</p>
 
 
</div>
 
 
<div class="column half_size">
 
<h3>Best Integrated Human Practices Special Prize</h3>
 
 
<p>
 
To compete for the <a href="https://2017.igem.org/Judging/Awards">Best Integrated Human Practices prize</a>, please describe your work on this page and also fill out the description on the <a href="https://2017.igem.org/Judging/Judging_Form">judging form</a>.
 
<br><br>
 
You must also delete the message box on the top of this page to be eligible for this prize.
 
</p>
 
</div>
 
<div class="clear"></div>
 
<div class="column full_size">
 
<h5>Inspiration</h5>
 
<p>Here are a few examples of excellent Integrated Human Practices work:</p>
 
<ul>
 
<li><a href="https://2016.igem.org/Team:INSA-Lyon/Integrated_Practices">2016 INSA Lyon</a></li>
 
<li><a href="https://2016.igem.org/Team:UofC_Calgary/Integrated_Practices">2016 UofC Calgary</a></li>
 
<li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Practices">2015 Bielefeld</a></li>
 
<li><a href="https://2015.igem.org/Team:Edinburgh/Practices">2015 Edinburgh</a></li>
 
</ul>
 
</html>
 

Revision as of 18:47, 29 October 2017

Integrated Human Practices

Human Practices Development

We have thought about the Human Practices since the very beginning of KILL XYL. We had drawn the limits of it and found out which actors were going to be involved in deciding our scientific approach. This way our project could be as adapted as possible to the factual needs of society.

Then, the more our project advanced and defined itself, the more we worked on the practical side of Human Practices.

First and foremost safety is crucial in a lab. To work in synthetic biology, we ask our self about the consequences of our manipulation and the safety level of each part and organisms that we used. We also always make sure to work with the best condition and we didn't experiment with P2 level organisms. We also wanted to make sure that our product, especially our phage-like particle as it is a GMO, is environmentally friendly and doesn't pollute the soil or harm plant. To do so, we did test our phages in various conditions.

To integrate the farmer’s opinion, we contacted them and did surveys, first via the web and then in person, during events around agriculture. This approach helped us to figure out their needs and their thoughts, about Xylella fastidiosa and the communication around it.

We got advices from different experts : Mireille Ansaldi, the research director of the phage cycle and bacteria metabolism in LCB CNRS; Marie-Agnès Jacques, INRA’s researcher specialised in X. fastidiosa, and Jacques Van Helden, professor in Aix-Marseille University in bioinformatics, genome analysis, and more specifically analyses of regulatory sequences.

Finally, in order to get advice on the relevance of our project we contacted Ms Jacques, a X. fastidiosa specialist from the Institut National de la Recherche Agronomique(INRA). She beware us that we would be defined by the legislation as a GMO product. We then began a complete study of french’s and European's law, thanks to a collaboration with the Paris-Saclay team to see if we will be able to sell our product in France and in Europe.

To sum up, our project grew entwined with the human practices.

  • T--Aix-Marseille--survey.pngSurvey
  • InterviewInterviews
  • LegislationLegislation
  • T--Aix-Marseille--Public.pngPublic Engagement